SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-009315
Filing Date
2020-01-31
Accepted
2020-01-31 16:36:01
Documents
3
Effectiveness Date
2020-01-31

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv537382-defa14a.htm DEFA14A 17289
2 GRAPHIC lg_titan-pharma.jpg GRAPHIC 24117
3 GRAPHIC sg_marcrubin-bw.jpg GRAPHIC 22800
  Complete submission text file 0001104659-20-009315.txt   83241
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-13341 | Film No.: 20565550
SIC: 2836 Biological Products, (No Diagnostic Substances)